Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cai, Yan | - |
dc.contributor.author | An, Seong Soo A. | - |
dc.contributor.author | Kim, SangYun | - |
dc.date.available | 2020-02-28T14:45:07Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 1178-1998 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/11885 | - |
dc.description.abstract | Alzheimer's disease (AD) is the most common form of dementia. Mutations in the genes encoding presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein have been identified as the main genetic causes of familial AD. To date, more than 200 mutations have been described worldwide in PSEN1, which is highly homologous with PSEN2, while mutations in PSEN2 have been rarely reported. We performed a systematic review of studies describing the mutations identified in PSEN2. Most PSEN2 mutations were detected in European and in African populations. Only two were found in Korean populations. Interestingly, PSEN2 mutations appeared not only in AD patients but also in patients with other disorders, including frontotemporal dementia, dementia with Lewy bodies, breast cancer, dilated cardiomyopathy, and Parkinson's disease with dementia. Here, we have summarized the PSEN2 mutations and the potential implications of these mutations in dementia-associated disorders. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | DOVE MEDICAL PRESS LTD | - |
dc.relation.isPartOf | CLINICAL INTERVENTIONS IN AGING | - |
dc.subject | FRONTOTEMPORAL LOBAR DEGENERATION | - |
dc.subject | AMYLOID PRECURSOR PROTEIN | - |
dc.subject | EARLY-ONSET DEMENTIA | - |
dc.subject | ENDOPLASMIC-RETICULUM | - |
dc.subject | MEDIATED ENHANCEMENT | - |
dc.subject | VARIABLE EXPRESSION | - |
dc.subject | SPLICE VARIANT | - |
dc.subject | GENE MUTATION | - |
dc.subject | PSEN2 GENE | - |
dc.subject | APOPTOSIS | - |
dc.title | Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000357880900004 | - |
dc.identifier.doi | 10.2147/CIA.S85808 | - |
dc.identifier.bibliographicCitation | CLINICAL INTERVENTIONS IN AGING, v.10, pp.1163 - 1172 | - |
dc.identifier.scopusid | 2-s2.0-84937438173 | - |
dc.citation.endPage | 1172 | - |
dc.citation.startPage | 1163 | - |
dc.citation.title | CLINICAL INTERVENTIONS IN AGING | - |
dc.citation.volume | 10 | - |
dc.contributor.affiliatedAuthor | Cai, Yan | - |
dc.contributor.affiliatedAuthor | An, Seong Soo A. | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | mutations in presenilin 2 | - |
dc.subject.keywordAuthor | Alzheimer&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordPlus | FRONTOTEMPORAL LOBAR DEGENERATION | - |
dc.subject.keywordPlus | AMYLOID PRECURSOR PROTEIN | - |
dc.subject.keywordPlus | EARLY-ONSET DEMENTIA | - |
dc.subject.keywordPlus | ENDOPLASMIC-RETICULUM | - |
dc.subject.keywordPlus | MEDIATED ENHANCEMENT | - |
dc.subject.keywordPlus | VARIABLE EXPRESSION | - |
dc.subject.keywordPlus | SPLICE VARIANT | - |
dc.subject.keywordPlus | GENE MUTATION | - |
dc.subject.keywordPlus | PSEN2 GENE | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.relation.journalResearchArea | Geriatrics & Gerontology | - |
dc.relation.journalWebOfScienceCategory | Geriatrics & Gerontology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.